Skip to main content

Table 5 Surgeons’ knowledge about the staging of PC

From: Surgeons’ knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study

Staging of Pancreatic Cancer Agree (%) Disagree (%) Unsure (%) Missing (%)
T-staging TX: Unable to judge 553(78.4) 95(13.5) 7(1.0) 50(7.1)
T0: No evidence of primary tumor 496(70.4) 168(23.8) 11(1.6) 30(4.3)
T1: Tumor limited to the pancreas, ≤2 cm in longest dimension 567(80.4) 102(14.5) 9(1.3) 27(3.8)
T2: Tumor limited to the pancreas, >2 cm in longest dimension 478(67.8) 163(23.1) 15(2.1) 49(7.0)
T3: Extension beyond the pancreas, no involvement of the celiac or the superior mesenteric artery 534(75.7) 109(15.5) 27(3.8) 35(5.0)
T4: Tumor involves the celiac or superior mesenteric artery 556(78.9) 106(15.0) 17(2.4) 26(3.7)
N-staging NX: Unable to judge 540(76.6) 97(13.8) 7(1.0) 61(8.7)
N0: No regional lymph node metastasis 612(86.8) 76(10.8) 5(0.7) 12(1.7)
N1: Regional lymph node metastasis 623(88.4) 50(7.1) 5(0.7) 27(3.8)
M-staging MX: Unable to judge 638(90.5) 22(3.1) 29(4.1) 16(2.3)
M0: No distant metastasis 569(80.7) 45(6.4) 47(6.7) 44(6.2)
M1: Distant metastasis 622(88.2) 58(8.2) 1(0.1) 24(3.4)